Session Name:APP Journal Club- New Tools, New Hope: GLP-1RAs in Adolescent Weight Management

Time: August 28, 2026, 12-1pm

We appreciate your time and effort in participating in this CME Sessional Evaluation. This evaluation is a pipeline to bring your voice to the leadership, instructors, and CME team. We value your voice and try our best to improve the quality of future activities.

Did/Will you use this information for specific patient(s)?
What patient/health care problem recently challenged you, and you wish you knew more about?
Comments and Feedback on the learning experience, content, procedure, and instructors, etc. in this session.
As a result of my participation in this activity, I am better able to... 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly disagree
1234
Review the current evidence for the safety, efficacy, and indications of GLP-1 receptor agonists in adolescents with obesity and related metabolic conditions
Identify appropriate patient selection criteria, monitoring strategies, and counseling considerations when prescribing GLP-1 receptor agonists in adolescent populations.
The following speaker(s) demonstrated experiential knowledge of the topic 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree
1234
Denise Kilway, DNP, APNP
Choose the option that best fits your evaluation of this activity: 4 - Strongly Agree 3- Agree 2 - Somewhat Disagree 1- Strongly Disagree
1234
The content provided a fair and balanced coverage of the topic
The content was free of commercial bias